Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

29 February 2016

Fragment events in 2016 (updated)

›
The first FBDD-related meeting of 2016 has already come and gone, but there are still plenty of events ahead. Below are several updates as w...
22 February 2016

Fragments vs PRMT6

›
Epigenetics involves turning genes on or off without changing their sequence. This often relies on modifications to proteins or DNA that a...
1 comment:
15 February 2016

Selectivity in STD

›
Among NMR-based fragment screening methods, saturation transfer difference ( STD ) came in as most popular in a recent poll . The technique...
2 comments:
08 February 2016

Dihydroisoquinolones as fragments

›
It’s a common problem: you find a fragment that binds to your target and want to grow it to improve affinity. A search for commercial analo...
6 comments:
01 February 2016

Fragment-Based Drug Discovery: Lessons and Outlook

›
In 2006, Wolfgang Jahnke and I co-edited the very first book on fragment-based drug discovery. Half a dozen books have followed, most of w...
2 comments:
25 January 2016

Fragments vs plasmepsins

›
Plasmodium , which causes malaria, is a nasty bag of tricks. These include the plasmepsins, aspartic proteases that – among other duties – ...
18 January 2016

Microscale thermophoresis revisited

›
One of the less commonly used fragment-finding methods is microscale thermophoresis ( MST ). This measures the movement of proteins in a t...
5 comments:
11 January 2016

Universal fragments for discovering hot spots and aiding crystallography

›
A couple years ago we highlighted a paper from Eddy Arnold’s group at Rutgers University in which crystallographic fragment screening reve...
06 January 2016

Secondary ligand binding sites are common

›
Anyone who has been exposed to much crystallography will have seen examples where a ligand binds somewhere besides the active site of a pro...
3 comments:
04 January 2016

Fragment events in 2016

›
Happy 2016! This looks like a good year for fragment events, so start planning now! February 21-24 :  Zing conferences is holding its inau...
30 December 2015

Review of 2015 reviews

›
In the Northern Hemisphere the winter solstice has passed but the days are still short, and 2015 is hurtling into history. As we did in 201...
1 comment:
21 December 2015

Pacifichem 2015

›
Last week saw the first-ever fragment-based symposium at Pacifichem . These are massive meetings held in Honolulu every 5 years to bring to...
2 comments:
14 December 2015

Fragments vs MKK3: modeling all the way to low nanomolar

›
The mitogen-activated protein kinase (MAPK) signaling pathway is a rich source of targets, particularly for inflammation. Within this casca...
07 December 2015

Fragments vs PDE10A revisited

›
Independent teams have reported using fragments to identify structurally distinct inhibitors against a popular psychiatric target. Last...
30 November 2015

Fragments vs GPCRs – virtually vs experimentally

›
G protein-coupled receptors (GPCRs) are common drug targets that present challenges for fragment-based approaches. Biophysical studies of t...
23 November 2015

Fragments vs DAPK3, computationally and experimentally

›
Computational approaches for discovering hits often involve sorting through many possibilities and examining a few closely. With luck, some...
16 November 2015

Fragments vs PDE10A: growing potency and selectivity

›
People often wonder how selective fragments need to be. According to molecular complexity theory , the answer is “not very”. After all, it ...
1 comment:
‹
›
Home
View web version
Powered by Blogger.